Gareth J Veal Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Clinical follow-up of high-risk neuroblastoma patients receiving individualised 13-cis-retinoic acid based on pharmacological exposure as part of a national UK study — Poster Session 2 with wine & cheese